Hextend (hetastarch) NDC 0409-1555

NDC codes

FDA NDC Directory

Product NDC (as listed)0409-1555Labeler and product segments. Claims need a package NDC.

Product NDC at billing width00409-1555Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package	Copy
0409-1555-54	00409155554	12 BAG in 1 CASE (0409-1555-54) / 500 mL in 1 BAG (0409-1555-64)Marketed from Feb 2, 2005

How the 11-digit form is made: The labeler segment has 4 digits, so one leading zero is added to it (4-4-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Hextend
Generic name (nonproprietary): hetastarch
Active ingredients: Hetastarch — 6 g/100mL
Dosage form: Injection, Solution
Route: Intravenous
Labeler: Hospira, Inc.
Product type: Prescription drug
Marketing category: NDA — New Drug ApplicationApplication BN 200952
Marketing start: Feb 2, 2005
Listing expires: Dec 31, 2027
Other FDA classes: Increased Intravascular Volume (Physiologic effect)Osmotic Activity (Mechanism)Starch (Chemical structure)
Identifiers: Product ID 0409-1555_9829894c-8ff3-4355-94d1-1cd61363db2cSPL ID 9829894c-8ff3-4355-94d1-1cd61363db2cSPL set ID fc79700c-6c3b-4998-8307-4dc8c81c5041RxCUI 310757, 404665UNII 875Y4127EA
Pharmacologic class: Plasma Volume Expander

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No drug-specific HCPCS code in Med-Code's directory for this product. The directory is curated and not complete — check the current CMS HCPCS file before billing.

Administration

Drug administration (CPT 96360–96549)

When a clinician administers the drug, the administration is reported separately. Codes in this range cover hydration, therapeutic injections and infusions, and chemotherapy or other complex drug administration. The right code depends on route, duration and drug type, and self-administered drugs are not billed this way.

How CPT relates to drug billing

NDC on a medical claim

N400409155554 followed by a unit qualifier and the quantity

Package 00409-1555-54. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective May 20, 2026. This label includes a boxed warning.

Indications (excerpt from the label)

INDICATIONS AND USAGE HEXTEND (6% Hetastarch in Lactated Electrolyte Injection) is indicated in the treatment of hypovolemia when plasma volume expansion is desired in settings where adequate alternative treatment is unavailable. It is not a substitute for blood or plasma.

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)